Kalbe Farma Valuation
| KLBF Stock | IDR 1,485 20.00 1.37% |
At this time, the firm appears to be overvalued. Kalbe Farma Tbk secures a last-minute Real Value of 1274.7 per share. The latest price of the firm is 1485.0. Our model forecasts the value of Kalbe Farma Tbk from analyzing the firm fundamentals such as Return On Equity of 0.17, current valuation of 95.3 T, and Profit Margin of 0.12 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Kalbe Farma's price fluctuation is very steady at this time. Calculation of the real value of Kalbe Farma Tbk is based on 3 months time horizon. Increasing Kalbe Farma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Kalbe Farma's intrinsic value may or may not be the same as its current market price of 1,485, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1485.0 | Real 1274.7 | Hype 1450.0 | Naive 1437.87 |
The intrinsic value of Kalbe Farma's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Kalbe Farma's stock price.
Estimating the potential upside or downside of Kalbe Farma Tbk helps investors to forecast how Kalbe stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kalbe Farma more accurately as focusing exclusively on Kalbe Farma's fundamentals will not take into account other important factors: Kalbe Farma Total Value Analysis
Kalbe Farma Tbk is now forecasted to have takeover price of 95.3 T with market capitalization of 104.08 T, debt of 532.51 B, and cash on hands of 3.32 T. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Kalbe Farma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
95.3 T | 104.08 T | 532.51 B | 3.32 T |
Kalbe Farma Investor Information
About 58.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 72.54. Kalbe Farma Tbk last dividend was issued on the 31st of May 2022. The entity had 5:1 split on the 8th of October 2012. Based on the key measurements obtained from Kalbe Farma's financial statements, Kalbe Farma Tbk is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Kalbe Farma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Kalbe Farma has an asset utilization ratio of 102.32 percent. This suggests that the Company is making 1.02 for each dollar of assets. An increasing asset utilization means that Kalbe Farma Tbk is more efficient with each dollar of assets it utilizes for everyday operations.Kalbe Farma Ownership Allocation
Kalbe Farma Tbk maintains a total of 46.26 Billion outstanding shares. Kalbe Farma Tbk holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Kalbe Farma Profitability Analysis
The company reported the revenue of 26.26 T. Net Income was 3.18 T with profit before overhead, payroll, taxes, and interest of 11.11 T.About Kalbe Farma Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Kalbe Farma Tbk. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kalbe Farma Tbk based exclusively on its fundamental and basic technical indicators. By analyzing Kalbe Farma's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Kalbe Farma's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kalbe Farma. We calculate exposure to Kalbe Farma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kalbe Farma's related companies.8 Steps to conduct Kalbe Farma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Kalbe Farma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Kalbe Farma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Kalbe Farma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Kalbe Farma's revenue streams: Identify Kalbe Farma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Kalbe Farma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Kalbe Farma's growth potential: Evaluate Kalbe Farma's management, business model, and growth potential.
- Determine Kalbe Farma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Kalbe Farma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Kalbe Stock
Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.